Commonwealth Equity Services’s Q32 Bio QTTB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q3
Sell
-588
Closed -$20K 3775
2022
Q2
$20K Sell
588
-151
-20% -$5.16K ﹤0.01% 3570
2022
Q1
$40K Buy
739
+28
+4% +$1.74K ﹤0.01% 3606
2021
Q4
$46K Buy
711
+58
+9% +$5.63K ﹤0.01% 3545
2021
Q3
$92K Buy
+653
New +$83.2K ﹤0.01% 3437

Other funds holding QTTB

Commonwealth Equity Services's QTTB Position: Q3 2022 in Review

Commonwealth Equity Services sold out of Q32 Bio (QTTB) in Q3 2022, closing a stake of 588 shares — an estimated $20K sold.

Commonwealth Equity Services first reported a position in QTTB in Q3 2021 and held it in 4 quarters. The position peaked at $92K in Q3 2021. 83 funds tracked by Wall St. Rank hold QTTB as of Q3 2022.

  • Commonwealth Equity Services reported no remaining Q32 Bio position as of Q3 2022 after selling out during the quarter.
  • Commonwealth Equity Services sold 588 Q32 Bio shares in Q3 2022, an estimated $20K.
  • Commonwealth Equity Services first reported a position in Q32 Bio in Q3 2021 and held it in 4 quarters.
  • Commonwealth Equity Services's Q32 Bio position peaked at $92K in Q3 2021.
  • 83 funds tracked by Wall St. Rank held Q32 Bio as of Q3 2022.

Based on Commonwealth Equity Services's 13F filing for Q3 2022, filed 14 Nov 2022.